this post was submitted on 12 Jun 2023
22 points (100.0% liked)

Science

13009 readers
21 users here now

Studies, research findings, and interesting tidbits from the ever-expanding scientific world.

Subcommunities on Beehaw:

Be sure to also check out these other Fediverse science communities:

This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago
MODERATORS
alyaza@beehaw.org
Gaywallet@beehaw.org
remington@beehaw.org
22
What field do you work in? (beehaw.org)
submitted 1 year ago* (last edited 1 year ago) by realChem@beehaw.org to c/science@beehaw.org
89 comments fedilink hide all child comments
 

I've been curious how many working researchers we've got in this community, and what you all do!

If you're working in science (physical or social), engineering, etc in a research capacity, give a shout in the comments and let us know what you work on! Same goes for students and amateur scientists at any level. (And by amateur I mean those of you who are working on your own experiments but just not being paid for it / not working on a degree; I'm upset that "amateur" has a negative connotation, it shouldn't.)

I'm currently a PhD candidate, working on transmission electron microscopy and electronic materials (mainly ferroelectrics). In the past I've been involved in research / product development in a few different industries, including medical devices, aerogels, and materials for RF devices.

you are viewing a single comment's thread
view the rest of the comments
[–] Dr_Cog@beehaw.org 5 points 1 year ago (1 children)

I'm a research professor of neurology, and my research focuses on developing novel cognitive assessments for measuring early-stage Alzheimer's disease and other types of dementia.

[–] realChem@beehaw.org 3 points 1 year ago (1 children)

That's a field where it seems (to an outsider) like a lot has been happening recently! Glad to have you here!

[–] Dr_Cog@beehaw.org 2 points 1 year ago

You'd be correct! The new anti-amyloid drugs are very exciting, and it makes my work on preclinical Alzheimer's even more fulfilling as it can have a real impact on getting people tested and treated as early as possible.